Assessment of Whole Gut Transit Time Using the SmartPill Capsule

NCT00603707 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2008-08-29

No results posted yet for this study

Summary

Our null hypothesis states that the two techniques (Sitzmarks radioopaque markers and SmartPill) are equivalent and is demonstrated if the study population shows a correlation of 0.7 or higher.

Conditions

Sponsors & Collaborators

  • The SmartPill Corporation

    lead INDUSTRY

Principal Investigators

  • Henry Parkman, MD · Temple University Medical Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00603707 on ClinicalTrials.gov